eJHaem (Feb 2022)

Leg‐type form of idiopathic multicentric Castleman disease associated with severe lower extremity chronic venous/lymphatic disease

  • Thomas Ballul,
  • Nabil Belfeki,
  • Adèle deMasson,
  • Véronique Meignin,
  • Paul‐Louis Woerther,
  • Antoine Martin,
  • Elsa Poullot,
  • Alain Wargnier,
  • Jehane Fadlallah,
  • Margaux Garzaro,
  • Marion Malphettes,
  • Claire Fieschi,
  • Lucas Maisonobe,
  • Hayat Bensekhri,
  • Hélène Guillot,
  • Rémi Bertinchamp,
  • Marie Jachiet,
  • Justine Poirot,
  • Lionel Galicier,
  • Eric Oksenhendler,
  • David Boutboul

DOI
https://doi.org/10.1002/jha2.353
Journal volume & issue
Vol. 3, no. 1
pp. 175 – 179

Abstract

Read online

Abstract Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disease of unknown etiology. Deciphering mechanisms involved in CD pathogenesis may help improving patients’ care. Six cases of stereotyped sub‐diaphragmatic iMCD affecting lower limb‐draining areas and associated with severe and often ulcerative lower extremity chronic dermatological condition were identified in our cohort. Pathological examination revealed mixed or plasma‐cell type MCD. In three patients, shotgun metagenomics failed to identify any pathogen in involved lymph nodes. Antibiotics had a suspensive effect while rituximab and tocilizumab failed to improve the condition. This novel entity requires a specific approach and exclusion of potentially harmful immunomodulation.

Keywords